Medindia
Medindia LOGIN REGISTER
Advertisement

Anti-Microcephaly Vaccine-Blocker Candidate: Based on Zika Virus Gene Replikins in Human Fetal Microcephaly

Wednesday, August 3, 2016 Tropical Disease News
Advertisement
TORONTO, Aug. 2, 2016 /PRNewswire/ -- Following the report earlier this month that significant mutations have been detected in Zika gene structures*, Replikins, Ltd. Canada announced today that particular Replikins structures have been found in the Zika virus genes of microcephaly cases.
Advertisement

Logo - http://photos.prnewswire.com/prnh/20160802/395058LOGO

Photo - http://photos.prnewswire.com/prnh/20160802/395059

These form the basis of the design of Synthetic Replikins Microcephaly Vaccine-Blocker candidates (Attached figure: all individual Zika specimens in Pubmed January, 2016, with Ebola for comparison).
Advertisement

Microcephaly of fetuses is the most dreaded outcome of the current Zika outbreaks. Replikins vaccine-blocker candidates appear to be the first to target the specific chemistry of the Zika virus gene related to microcephaly.

Replikins vaccines are produced in as little as seven days by solid phase synthesis, freeze-dried, permitting delivery without refrigeration (Google: "Replikins Reuters").

Contact:  Samuel Bogoch  Email  646-320-5910  www.replikins.com

 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/anti-microcephaly-vaccineblocker-candidate-based-on-zika-virus-gene-replikins-in-human-fetal-microcephaly-300307869.html

SOURCE Replikins Ltd.

Sponsored Post and Backlink Submission


Latest Press Release on Tropical Disease News

This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close